Skip to main content

Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus  MERS-CoV developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate models when given intradermally in abbreviated, low-dose immunization regimen. A similar vaccine candidate was previously shown to be safe and tolerable with a three-dose intramuscular injection regimen in a recently completed human phase 1 study and is currently in expanded studies of phase 1/2a trial.

Leo Pharma gets CHMP nod for Adtralza for dermatitis

LEO Pharma A/S, a global leader in medical dermatology announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization of Adtralza (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy.

US-India Strategic Partnership Forum Extends Support for Indias COVID Crisis Response

US-India Strategic Partnership Forum and members appreciate the efforts by leaders across the U.S. government at the highest level to identify concrete steps the United States can take to assist India through this crisis. The company looks forward to announcements soon that will support India’s efforts to fill needs like oxygen, medicines, medical supplies, and vaccines. This should include a waiver of current restrictions on the export of vaccine raw materials to ensure production of vaccine in India can continue uninterrupted.

Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevacizumab

Biocon Biologics Ltd., a subsidiary of Biocon Ltd has announced that Abevmy 100 and 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc. has received marketing authorization approval from the European Commission following the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency.

Recruitment for Pharmacists in Covid Care Centre at Indian Railways, Salary Rs 40000 pm

South Central Railway was formed on 02.10.1966 when Hubli and Vijayawada Divisions of Southern Railway and Sholapur and Secunderabad Divisions of Central Railway were carved out and merged into a new Zone. Subsequently, Guntakal Division of Southern Railway was merged with South Central Railway on 02.10.1977 and Sholapur Division was remerged with Central Railway. Secunderabad Division was split into two Divisions viz. Secunderabad and Hyderabad on 17.02.1978.

Online Interview for Junior Research Fellow at IIT | M.Pharm

Indian Institute of Technology Guwahati, the sixth member of the IIT fraternity, was established in 1994. The academic programme of IIT Guwahati commenced in 1995. At present the Institute has eleven departments and five inter-disciplinary academic centres covering all the major engineering, science and humanities disciplines, offering BTech, BDes, MA, MDes, MTech, MSc and PhD programmes.

Recruitment for Assistant Professor, Associate Professor and Professor at Sanjay College of Pharmacy

Sanjay College of Pharmacy, Mathura established in the year 2007. The Institute offers, full time four-year degree course in Pharmacy (B.Pharm) and Two years (D.Pharm). The institute is located in a peaceful & Pollution free environment, which has an attractive building comprising of administrative block, Lecture halls, laboratories, Library, Medicinal garden, Lush green lawns & play grounds.

Vacancy for Scientist at C-DAC | Government of India Job

Centre for Development of Advanced Computing (C-DAC), is a scientific society of the Department of Information Technology under the Ministry of Communications and Information Technology, Government of India. C-DAC has today emerged as a premier R&D organization in ICT&E (Information, Communications Technologies and Electronics) in the country, working on strengthening national technological capabilities in the context of global developments in the field and responding to change in the market need in selected foundation areas.

Life Sciences recruitment in SERB funded research project at RGCB

The Rajiv Gandhi Centre for Biotechnology (RGCB) is an autonomous national institute of the Government of India, Ministry for Science & Technology, Department of Biotechnology. The mandate of the institute is discovery, innovation and translation in biotechnology and disease biology. At RGCB, our todays are committed to making discoveries that lead to a better tomorrow. RGCB prides itself for innovative research that integrates theory, modeling, simulation, experimental translational and clinical sciences.

Unilever looking for R&D Associate

Be part of the world’s most successful, purpose-led business. Work with brands that are well-loved around the world, that strive to improve the lives of our consumers and the communities around us every day. Every day, nine out of ten Indian households use our products to feel good, look good and get more out of life – giving us a unique opportunity to build a brighter future. We promote innovation, big and small, to make our business win and grow; and we believe in business as a force for good.

PhD positions in Pharmaceutical Nanotechnology at Uppsala University

Uppsala University is a comprehensive research-intensive university with a strong international standing. Our ultimate goal is to conduct education and research of the highest quality and relevance to make a long-term difference in society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces.

M.Pharm, B.Pharm, M.Sc Job in Himalaya Wellness

Himalaya began its journey at a time when herbal products were regarded with skepticism. But, our founder persevered to follow his dreams. Pawning his mother's bangles, he bought a hand-operated tableting machine.

Post : Associate / Senior Associate E-Sourcing

Maithri Drugs - walk in Interview for AR&D Department

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved.

API DIVISION : AR&D DEPARTMENT

Jobs for Pharma Fellows (12 posts) under Ministry of Science & Technology

Clinical Development Services Agency (CDSA) mission is to create, develop, and nurture world-class clinical product development capacity in India.

Post: Senior Research Fellow, 12 Positions

M.Pharm, M.Sc, B.Pharm Recruitment in Research project funded by Department of Biotechnology

Indian Institute of Science Education and Research Pune is a premier autonomous Institution established by the Ministry of Education, Government of India, for promotion of high quality science education and research in the country.

Research Recruitment for Ph.D at NIPER

National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad is an "Institute of National Importance" with proclaimed objectives of becoming Centre of Excellence for advanced research in pharmaceutical sciences. NIPER-Mohali was the first institute established in the year 1998 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Job for M.Pharm to work in ICMR Funded project at Institute of Life Sciences

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from Indian Nationals to join in the following position.

Post : Junior Research Fellow (01 position)

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings (posted on SSRN/Preprints with The Lancet) they note that they are the first to meet the World Health Organization's Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75% efficacy.

Biological E. Limited Gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate

Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) - Subject Expert Committee (SEC).

Postdoctoral Pharma Position under DST Funded project at IIT

Indian Institute of Technology Indore located in Madhya Pradesh, known as IIT Indore or IITI, is an institute of national importance established by the Government of India in 2009. It is one of the eight new IITs, started by the Ministry of Human Resource Development, Government of India. The institution started functioning from 2009-10 in a temporary campus at Institute of Engineering and Technology of Devi Ahilyabai University under mentorship of IIT Bombay.

Subscribe to